100 related articles for article (PubMed ID: 7742316)
21. Binding characteristics of Ustilago maydis topoisomerase I to DNA containing secondary structures.
Thiyagarajan MM; Waldman SA; Noè M; Kmiec EB
Eur J Biochem; 1998 Jul; 255(2):347-55. PubMed ID: 9716375
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification.
Wang X; Wang LK; Kingsbury WD; Johnson RK; Hecht SM
Biochemistry; 1998 Jun; 37(26):9399-408. PubMed ID: 9649322
[TBL] [Abstract][Full Text] [Related]
23. Kinetic analysis of DNA and RNA strand transfer reactions catalyzed by vaccinia topoisomerase.
Sekiguchi J; Cheng C; Shuman S
J Biol Chem; 1997 Jun; 272(25):15721-8. PubMed ID: 9188465
[TBL] [Abstract][Full Text] [Related]
24. Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases.
Klemm M; Cheng C; Cassell G; Shuman S; Segall AM
J Mol Biol; 2000 Jun; 299(5):1203-16. PubMed ID: 10873446
[TBL] [Abstract][Full Text] [Related]
25. Vaccinia topoisomerase and Cre recombinase catalyze direct ligation of activated DNA substrates containing a 3'-para-nitrophenyl phosphate ester.
Woodfield G; Cheng C; Shuman S; Burgin AB
Nucleic Acids Res; 2000 Sep; 28(17):3323-31. PubMed ID: 10954601
[TBL] [Abstract][Full Text] [Related]
26. Site-specific interaction of vaccinia virus topoisomerase I with base and sugar moieties in duplex DNA.
Shuman S; Turner J
J Biol Chem; 1993 Sep; 268(25):18943-50. PubMed ID: 7689562
[TBL] [Abstract][Full Text] [Related]
27. Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugates.
Arimondo PB; Angenault S; Halby L; Boutorine A; Schmidt F; Monneret C; Garestier T; Sun JS; Bailly C; Hélène C
Nucleic Acids Res; 2003 Jul; 31(14):4031-40. PubMed ID: 12853620
[TBL] [Abstract][Full Text] [Related]
28. Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae.
Zhu J; Schiestl RH
Mol Cell Biol; 1996 Apr; 16(4):1805-12. PubMed ID: 8657156
[TBL] [Abstract][Full Text] [Related]
29. Deletions at the carboxyl terminus of vaccinia DNA topoisomerase affect DNA binding and enhance distributivity in DNA relaxation.
Wang LK; Shuman S
Biochemistry; 1997 Apr; 36(13):3909-16. PubMed ID: 9092821
[TBL] [Abstract][Full Text] [Related]
30. SFV topoisomerase: sequence specificity in a genetically mapped interval.
Palaniyar N; Fisher C; Parks R; Evans DH
Virology; 1996 Jul; 221(2):351-4. PubMed ID: 8661446
[TBL] [Abstract][Full Text] [Related]
31. Resolution of Holliday junctions by eukaryotic DNA topoisomerase I.
Sekiguchi J; Seeman NC; Shuman S
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):785-9. PubMed ID: 8570635
[TBL] [Abstract][Full Text] [Related]
32. Site-specific DNA transesterification by vaccinia topoisomerase: role of specific phosphates and nucleosides.
Cheng C; Shuman S
Biochemistry; 1999 Dec; 38(50):16599-612. PubMed ID: 10600122
[TBL] [Abstract][Full Text] [Related]
33. Requirements for noncovalent binding of vaccinia topoisomerase I to duplex DNA.
Sekiguchi J; Shuman S
Nucleic Acids Res; 1994 Dec; 22(24):5360-5. PubMed ID: 7816626
[TBL] [Abstract][Full Text] [Related]
34. Unmasking Anticooperative DNA-binding interactions of vaccinia DNA topoisomerase I.
Nagarajan R; Stivers JT
Biochemistry; 2007 Jan; 46(1):192-9. PubMed ID: 17198389
[TBL] [Abstract][Full Text] [Related]
35. A novel suicide substrate for DNA topoisomerases and site-specific recombinases.
Burgin AB; Huizenga BN; Nash HA
Nucleic Acids Res; 1995 Aug; 23(15):2973-9. PubMed ID: 7659520
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the interaction between topoisomerase II and DNA by transcriptional footprinting.
Thomsen B; Bendixen C; Lund K; Andersen AH; Sørensen BS; Westergaard O
J Mol Biol; 1990 Sep; 215(2):237-44. PubMed ID: 2170662
[TBL] [Abstract][Full Text] [Related]
37. Site-specific topoisomerase I-mediated DNA cleavage induced by nogalamycin: a potential role of ligand-induced DNA bending at a distal site.
Sim SP; Pilch DS; Liu LF
Biochemistry; 2000 Aug; 39(32):9928-34. PubMed ID: 10933812
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Mycobacterium smegmatis topoisomerase I by specific oligonucleotides.
Bhaduri T; Basak S; Sikder D; Nagaraja V
FEBS Lett; 2000 Dec; 486(2):126-30. PubMed ID: 11113452
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms for the processing of a frozen topoisomerase-DNA conjugate by human cell-free extracts.
Sastry S; Ross BM
J Biol Chem; 1998 Apr; 273(16):9942-50. PubMed ID: 9545338
[TBL] [Abstract][Full Text] [Related]
40. The Top1 paradox: Friend and foe of the eukaryotic genome.
Kim N; Jinks-Robertson S
DNA Repair (Amst); 2017 Aug; 56():33-41. PubMed ID: 28641942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
